Michael A Rocca - Net Worth and Insider Trading
Michael A Rocca Net Worth
The estimated net worth of Michael A Rocca is at least $5 Million dollars as of 2024-11-10. Michael A Rocca is the Director of Hyatt Hotels Corp and owns about 20,219 shares of Hyatt Hotels Corp (H) stock worth over $3 Million. Michael A Rocca is the Director of St Jude Medical Inc and owns about 16,447 shares of St Jude Medical Inc (STJ) stock worth over $1 Million. Michael A Rocca is also the Director of Ligand Pharmaceuticals Inc and owns about 1,333 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $161,546. Details can be seen in Michael A Rocca's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael A Rocca has not made any transactions after 2024-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael A Rocca
Michael A Rocca Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael A Rocca owns 3 companies in total, including Hyatt Hotels Corp (H) , St Jude Medical Inc (STJ) , and Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Michael A Rocca’s form 4 insider trades.
Insider Ownership Summary of Michael A Rocca
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
H | Hyatt Hotels Corp | 2024-06-13 | director |
STJ | St Jude Medical Inc | 2017-01-04 | director |
LGND | Ligand Pharmaceuticals Inc | 2006-09-27 | director |
Michael A Rocca Latest Holdings Summary
Michael A Rocca currently owns a total of 3 stocks. Among these stocks, Michael A Rocca owns 20,219 shares of Hyatt Hotels Corp (H) as of June 13, 2024, with a value of $3 Million and a weighting of 67.79%. Michael A Rocca owns 16,447 shares of St Jude Medical Inc (STJ) as of February 6, 2014, with a value of $1 Million and a weighting of 28.72%. Michael A Rocca also owns 1,333 shares of Ligand Pharmaceuticals Inc (LGND) as of January 2, 2004, with a value of $161,546 and a weighting of 3.49%.
Latest Holdings of Michael A Rocca
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
H | Hyatt Hotels Corp | 2024-06-13 | 20,219 | 155.17 | 3,137,382 |
STJ | St Jude Medical Inc | 2014-02-06 | 16,447 | 80.82 | 1,329,247 |
LGND | Ligand Pharmaceuticals Inc | 2004-01-02 | 1,333 | 121.19 | 161,546 |
Holding Weightings of Michael A Rocca
Michael A Rocca Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael A Rocca has made a total of 6 transactions in Hyatt Hotels Corp (H) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Hyatt Hotels Corp is the sale of 1,189 shares on June 13, 2024, which brought Michael A Rocca around $177,779.
According to the SEC Form 4 filings, Michael A Rocca has made a total of 0 transactions in St Jude Medical Inc (STJ) over the past 5 years. The most-recent trade in St Jude Medical Inc is the sale of 5,600 shares on February 6, 2014, which brought Michael A Rocca around $338,016.
According to the SEC Form 4 filings, Michael A Rocca has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 1,486 shares on January 2, 2004, which brought Michael A Rocca around $133,695.
Insider Trading History of Michael A Rocca
- 1
Michael A Rocca Trading Performance
GuruFocus tracks the stock performance after each of Michael A Rocca's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael A Rocca is -0.09%. GuruFocus also compares Michael A Rocca's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael A Rocca within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael A Rocca's insider trading performs compared to the benchmark.
Performance of Michael A Rocca
Michael A Rocca Ownership Network
Ownership Network List of Michael A Rocca
Ownership Network Relation of Michael A Rocca
Michael A Rocca Owned Company Details
What does Hyatt Hotels Corp do?
Who are the key executives at Hyatt Hotels Corp?
Michael A Rocca is the director of Hyatt Hotels Corp. Other key executives at Hyatt Hotels Corp include See Remarks David Udell , director & President & CEO Mark Samuel Hoplamazian , and See Remarks Joan Bottarini .
Hyatt Hotels Corp (H) Insider Trades Summary
Over the past 18 months, Michael A Rocca made 2 insider transaction in Hyatt Hotels Corp (H) with a net sale of 2,697. Other recent insider transactions involving Hyatt Hotels Corp (H) include a net sale of 32,321 shares made by Mark R Vondrasek , a net sale of 19,500 shares made by Joan Bottarini , and a net sale of 335,896 shares made by Mark Samuel Hoplamazian .
In summary, during the past 3 months, insiders sold 1,837,314 shares of Hyatt Hotels Corp (H) in total and bought 0 shares, with a net sale of 1,837,314 shares. During the past 18 months, 7,113,032 shares of Hyatt Hotels Corp (H) were sold and 1,250 shares were bought by its insiders, resulting in a net sale of 7,111,782 shares.
Hyatt Hotels Corp (H)'s detailed insider trading history can be found in Insider Trading Tracker table.
Hyatt Hotels Corp Insider Transactions
Michael A Rocca Mailing Address
Above is the net worth, insider trading, and ownership report for Michael A Rocca. You might contact Michael A Rocca via mailing address: C/o Ligand Pharmaceuticals Incorporated, 10275 Science Center Drive, San Diego Ca 92121.